Research Education Component
研究教育部分
基本信息
- 批准号:10666628
- 负责人:
- 金额:$ 20.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaApplications GrantsAreaAwardBindingBiological MarkersClinicalCollaborationsCommunicationComplementConsultationsContinuing EducationCoupledData ScienceDatabasesDementiaDevelopmentDiagnosisEducationElementsEvaluationFacultyFeedbackFertilizationFosteringFundingFutureGeneticGoalsGrantHuman ResourcesImaging technologyIndianaIndividualInformaticsInfrastructureKentuckyKnowledgeLaboratoriesLeadershipLinkMeasuresMentorsMissionModelingMolecular BiologyNerve DegenerationNeurodegenerative DisordersNeurosciencesNotificationParticipantPathway interactionsPeer ReviewPerformancePostdoctoral FellowPublicationsRecommendationResearchResearch PersonnelResearch Project SummariesResearch SupportResourcesScientistServicesStudentsTeacher Professional DevelopmentTimeTrainingTranslatingUnderrepresented MinorityUnderrepresented PopulationsUniversitiesUpdateWorkbrain healthcareercareer developmentdementededucation researchexperienceimprovedinnovationmemberneuroimagingneuropathologynext generationnovelpeerpeer coachingposterspreventprogramsrecruitresearch and developmentskillssuccesssymposiumsynergismtranslational scientist
项目摘要
Project Summary – Research Education Component (REC)
Alzheimer’s disease (AD) research has been at the forefront of neuroscience due to its substantive innovations
in molecular biology, genetics, neuropathology, and imaging technologies. Nevertheless, a critical need still
exists for professionals with specialized training to bring basic and clinical neuroscience of AD into the next
generation. REC’s goal is to develop new researchers specifically trained to discover innovative approaches to
improve understanding, diagnosis, and treatment of AD and other dementias. REC’s significance is fostering the
mission of the IADRC to stimulate education, information, and training; coordinate across laboratories; and
evaluate success in research education. REC’s objective is to synergize with the concepts of other cores,
including Biomarkers, Neuroimaging, Dementia Clinical Core, Neuropathology, Genetics and Data Science (or
simply BiNDiNGS) to students/trainees to provide leadership in training, career development, and dissemination
activities of the different Cores, thereby expanding current and future research by mentoring new scientists to
be well-prepared in this transdisciplinary area and poised to make important contributions. The REC will expand
current and future research by fostering new scientists from diverse backgrounds, including underrepresented
minorities (URMs), well-prepared in this transdisciplinary area, and who are poised to make important
contributions. Fostering local, regional, and national collaborations of early career investigators will significantly
advance the field of AD research.
REC’s five Specific Aims are:
1) Provide organizational infrastructure within IADRC for research education
2) Instill integrated fundamental knowledge of brain health and dementing illnesses
3) Recruit, retain, and assist students and faculty at multiple career levels
4) Define specific metrics to assess the progress of REC in its service of mentees
5) Foster cross-disciplinary interactions and collaborations in research education among IADRC cores
项目摘要-研究教育部分(REC)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DEBOMOY K LAHIRI其他文献
DEBOMOY K LAHIRI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DEBOMOY K LAHIRI', 18)}}的其他基金
Alzheimer's disease-linked microRNA Exploration of UTR Polymorphisms (AdmiRE-UP)
阿尔茨海默病相关 microRNA UTR 多态性探索 (AdMRE-UP)
- 批准号:
10391153 - 财政年份:2022
- 资助金额:
$ 20.05万 - 项目类别:
Brain protein alteration by vascular overexpressed miRNA (BravomiR)
血管过度表达 miRNA (BravomiR) 改变脑蛋白
- 批准号:
10392051 - 财政年份:2022
- 资助金额:
$ 20.05万 - 项目类别:
Role of microRNA in regulating Fe, Amyloid, and Tau (FeAT) in Alzheimer's disease
microRNA 在阿尔茨海默病中调节 Fe、淀粉样蛋白和 Tau (FeAT) 的作用
- 批准号:
10460800 - 财政年份:2021
- 资助金额:
$ 20.05万 - 项目类别:
Testing a Novel Approach to Solve the On-target, Off-site Effects of Alzheimer's Drugs
测试一种解决阿尔茨海默病药物的在靶、异位效应的新方法
- 批准号:
9456159 - 财政年份:2019
- 资助金额:
$ 20.05万 - 项目类别:
Administrative Supplement: Neurobiological role of MicroRNA in Alzheimer's
行政补充:MicroRNA 在阿尔茨海默病中的神经生物学作用
- 批准号:
9321507 - 财政年份:2015
- 资助金额:
$ 20.05万 - 项目类别:
Neurobiological Role of MicroRNA in Alzheimer's
MicroRNA 在阿尔茨海默病中的神经生物学作用
- 批准号:
9134034 - 财政年份:2015
- 资助金额:
$ 20.05万 - 项目类别:
Neurobiological Role of MicroRNA in Alzheimer's
MicroRNA 在阿尔茨海默病中的神经生物学作用
- 批准号:
10901008 - 财政年份:2015
- 资助金额:
$ 20.05万 - 项目类别:
Neurobiological Role of MicroRNA in Alzheimer's
MicroRNA 在阿尔茨海默病中的神经生物学作用
- 批准号:
9483583 - 财政年份:2015
- 资助金额:
$ 20.05万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 20.05万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 20.05万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 20.05万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 20.05万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 20.05万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 20.05万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 20.05万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 20.05万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 20.05万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 20.05万 - 项目类别:














{{item.name}}会员




